Assessment of Invasive Genetic Testing in Fetuses With Isolated Intrauterine Growth Restriction Diagnosed After 28 Weeks of Gestation at Strasbourg University Hospitals (2016-2023)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorUniversity Hospital, Strasbourg, France

About this trial

This study evaluates the diagnostic yield of invasive genetic testing in fetuses with isolated intrauterine growth restriction diagnosed after 28 weeks of gestation, in order to better define indications for invasive procedures and improve clinical counseling.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Maternal age ≥ 18 years

Referral after 28 weeks of gestation for estimated fetal weight < 3rd percentile, isolated condition

Management at Strasbourg University Hospitals between 01/01/2016 and 01/01/2023

No documented opposition to reuse of medical data for research

Disqualifiers

Suspected fetal structural anomaly or infectious cause

Multiple pregnancy

Incomplete genetic workup

Trial population

Pregnant women managed at Strasbourg University Hospitals with isolated intrauterine growth restriction diagnosed after 28 weeks of gestation between 2016 and 2023.

Trial design

Design model

Case-only

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Diagnostic yield of invasive genetic testing in isolated IUGR

Proportion of invasive prenatal procedures identifying a genetic abnormality explaining the intrauterine growth restriction

Time frame
2016-2023 retrospective period

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.